Wong, Carlos K. H. http://orcid.org/0000-0002-6895-6071
Lau, Jonathan J.
Au, Ivan C. H.
Lau, Kristy T. K.
Hung, Ivan F. N. http://orcid.org/0000-0002-1556-2538
Peiris, Malik http://orcid.org/0000-0001-8217-5995
Leung, Gabriel M. http://orcid.org/0000-0002-2503-6283
Wu, Joseph T. http://orcid.org/0000-0002-3155-5987
Funding for this research was provided by:
Food and Health Bureau of the Government of the Hong Kong Special Administrative Region | Health and Medical Research Fund (CID-HKU2, COVID190210)
Innovation and Technology Commission (AIR@InnoHK)
Article History
Received: 16 April 2023
Accepted: 17 November 2023
First Online: 16 December 2023
Competing interests
: C.K.H.W. reports the receipt of the General Research Fund, Research Grant Council, Government of Hong Kong SAR; EuroQol Research Foundation; AstraZeneca and Boehringer Ingelheim, all outside the submitted work. I.F.N.H. is an advisory board member for Pfizer, MSD, AstraZeneca, Moderna, and GSK. The remaining authors declare no competing interests.